Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Neuroimmunomodulation, S. Karger AG, Vol. 20, No. 5 ( 2013), p. 294-303
    Abstract: 〈 b 〉 〈 i 〉 Background/Aims: 〈 /i 〉 〈 /b 〉 Multiple sclerosis (MS) causes significant neurological disability. Experimental autoimmune encephalomyelitis (EAE) is an animal model of MS. Human bone marrow mesenchymal stem cells (hMSCs) possess anti-inflammatory and immunosuppressive effects. We studied whether hMSCs affect CD1d 〈 sup 〉 high 〈 /sup 〉 CD5 〈 sup 〉 + 〈 /sup 〉 regulatory B-cell activity in EAE. 〈 b 〉 〈 i 〉 Methods: 〈 /i 〉 〈 /b 〉 EAE was induced in C57BL/6N mice by immunization with MOG 〈 sub 〉 35-55 〈 /sub 〉 peptide. hMSCs were injected intravenously into EAE mice on day 3 and day 12 after first immunization. Mice were sacrificed on day 26. Immunohistochemistry of the spinal cord, serum cytokines levels, production of cytokines by cultured splenic cells, and flow cytometry for splenic Th17 and CD1d 〈 sup 〉 high 〈 /sup 〉 CD5 〈 sup 〉 + 〈 /sup 〉 regulatory B cells were studied. 〈 b 〉 〈 i 〉 Results: 〈 /i 〉 〈 /b 〉 EAE mice with hMSC treatment on day 3 and day 12 had reduced EAE scores from day 14 to day 26 compared to EAE mice without hMSC treatment, and reduced infiltration of inflammatory cells and demyelination in the spinal cord. EAE mice with hMSC treatment on day 3 and day 12 had: (1) lower serum levels of IL-6, TNF-α (p 〈 0.0005), and IL-17 (p 〈 0.005 for day 3, p 〈 0.0005 for day 12); (2) reduced splenic cell production and secretion of IL-6, TNF-α (p 〈 0.05), and IL-17 (p 〈 0.05), and increased splenic production of IL-10; (3) reduced splenic Th17 cells (p 〈 0.05 for day 3, p 〈 0.005 for day 12), and (4) increased CD1d 〈 sup 〉 high 〈 /sup 〉 CD5 〈 sup 〉 + 〈 /sup 〉 regulatory B cells (p 〈 0.005) compared to EAE mice without hMSC treatment. 〈 b 〉 〈 i 〉 Conclusion: 〈 /i 〉 〈 /b 〉 hMSC treatment on day 3 and day 12 suppresses EAE severity. The underlying mechanisms involve downregulation of Th17 cells and upregulation of CD1d 〈 sup 〉 high 〈 /sup 〉 CD5 〈 sup 〉 + 〈 /sup 〉 regulatory B-cell activity.
    Type of Medium: Online Resource
    ISSN: 1021-7401 , 1423-0216
    Language: English
    Publisher: S. Karger AG
    Publication Date: 2013
    detail.hit.zdb_id: 1483035-8
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages